IRON SUCROSE COMPLEX solution for injection/concentrate solution for infusion

Strength: 0.5 mg/cap Therapeutic area: Benign Prostatic Hyperplasia Innovator: Avodart (GSK)

Strength: 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Migraine Treatment Innovator: Relpax (Pfizer)

Strength: 10 mg/tab Therapeutic area: Primary Hypercholesterolaemia, Homozygous Familial Hypercholesterolaemia, Homozygous Sitosterolaemia Innovator: Ezetrol (Merck & Co)

Strength: 695 mg (80 mg/Fe++)/sachet Presentation: single dose sachet Therapeutic area: Iron Deficiency Innovator: Viofer (Viofar)

Strength: 20 mcg/ml; 100 mcg/ml Presentation: ampoules, 0.5 ml (100 mcg/ml); 1 ml (20 mcg/ml & 100 mcg/ml); 2.5 ml (20 mcg/ml) Therapeutic area: Severe peripheral arterial occlusive disease (PAOD) Innovator: Ilomedin (Bayer)

Strength: 10 mcg/ml; 20 mcg/ml Presentation: ampoules, 1 ml & 2 ml Therapeutic area: Pulmonary hypertension Innovator: Ventavis (Bayer)

Strength: (50 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalacom (Pfizer)

Strength: 50 mcg/ml Presentation: vial, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)

Strength: 50 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer)

Strength: 1 g/5 ml; 2 g/5 ml Presentation: ampoules, 5 ml Therapeutic area: Carnitine Deficiency Innovator: Carnitor (Sigma-Tau)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)